de Mora, Fernando http://orcid.org/0000-0002-3002-6004
Article History
First Online: 7 June 2019
Compliance with Ethical Standards
:
: No funding was received for the drafting of this review.
: Within the past 5 years, Dr de Mora has served as speaker/consultant for assorted pharmaceutical companies (including Amgen, Biogen, Celltrion, Finox, Gebro, Hikma, Hospira, KernPharma, Lilly, Mylan, Pfizer, Roche, Sandoz, Stada, and Theramex) producing biosimilars or original biologics and for biosimilar company associations. He also collaborates with healthcare administrations and other non-governmental organizations from European and non-European jurisdictions on biosimilar science, regulation, clinical use, and market trends.